Artelo Biosciences AAQS 2024

Τι κάνει η Artelo Biosciences;

Artelo Biosciences Inc is an innovative biopharmaceutical company specializing in the research and development of new therapies for the treatment of cancer and inflammatory diseases. The company was founded in 2011 and is headquartered in Manchester, UK, with a branch office in San Diego, USA. Artelo Biosciences Inc began with the discovery of new drug candidates based on the body's endocannabinoid system, which plays a crucial role in regulating various physiological processes such as pain, inflammation, mood, and appetite. The company's business model is based on identifying and researching new drug candidates based on the endocannabinoid system, as well as developing and marketing new therapies for the treatment of cancer and inflammatory diseases. Artelo Biosciences Inc operates in various sectors, including cancer therapy, inflammation inhibition, and neurological disorders. In cancer therapy, the company focuses on the development of new drugs for the treatment of solid tumors, particularly triple-negative breast cancer (TNBC), a highly aggressive type of cancer for which there are currently limited therapy options. Artelo Biosciences Inc has several promising drug candidates, including ART27.13, a synthetic cannabinoid receptor agonist that has shown in preclinical studies to inhibit the growth of TNBC cells. In inflammation inhibition, Artelo Biosciences Inc focuses on the development of new drugs for the treatment of diabetes, obesity, and inflammatory bowel diseases. The company has several promising drug candidates, including ART26.12, a synthetic endocannabinoid receptor agonist that has shown in preclinical studies to reduce inflammation in the intestine and improve insulin sensitivity. In neurological therapy, Artelo Biosciences Inc focuses on the development of new drugs for the treatment of anxiety and pain. The company has several promising drug candidates, including ART12.11, a synthetic endocannabinoid receptor agonist that has shown in preclinical studies to reduce anxiety and inhibit pain perception. Artelo Biosciences Inc closely collaborates with leading academic institutions and research centers to develop and test its drug candidates. The company has a strong research and development department composed of highly qualified scientists and clinicians. It also has an effective licensing and marketing strategy to bring its products to market. In summary, Artelo Biosciences Inc is an innovative biopharmaceutical company specializing in the research and development of new therapies for the treatment of cancer and inflammatory diseases. The company's business model is based on identifying and researching new drug candidates based on the endocannabinoid system, as well as developing and marketing new therapies. The company operates in various sectors, including cancer therapy, inflammation inhibition, and neurological disorders. Artelo Biosciences Inc has its own patents and licenses, a strong research and development department, and an effective licensing and marketing strategy to bring its products to market. Artelo Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.